{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T02:21:11Z","timestamp":1791512471102,"version":"4.3.4"},"reference-count":95,"publisher":"SAGE Publications","issue":"8","license":[{"start":{"date-parts":[[2018,5,18]],"date-time":"2018-05-18T00:00:00Z","timestamp":1526601600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"name":"NIH","award":["Kirschstein-NRSA 2T32HD007505-21"],"award-info":[{"award-number":["Kirschstein-NRSA 2T32HD007505-21"]}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01-NS080821"],"award-info":[{"award-number":["R01-NS080821"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["UM1-AI110557"],"award-info":[{"award-number":["UM1-AI110557"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Mult Scler"],"published-print":{"date-parts":[[2018,7]]},"abstract":"<jats:p>New potent immunomodulatory therapies for multiple sclerosis (MS) are associated with increased risk for progressive multifocal leukoencephalopathy (PML). It is unclear why a subset of treated patients develops PML, but patient age has emerged as an important risk factor. PML is caused by the JC virus and aging is associated with immune senescence, which increases susceptibility to infection. With the goal of improving PML risk stratification, we here describe the lymphocyte changes that occur with disease-modifying therapies (DMTs) associated with high or moderate risk toward PML in MS patients, how these changes compare to immune aging, and which measures best correlate with risk. We reviewed studies examining how these therapies alter patient immune profiles, which revealed the induction of changes to lymphocyte number and\/or function that resemble immunosenescence. Therefore, the immunosuppressive activity of these MS DMTs may be enhanced in the context of an immune system that is already exhibiting features of senescence.<\/jats:p>","DOI":"10.1177\/1352458518775550","type":"journal-article","created":{"date-parts":[[2018,5,18]],"date-time":"2018-05-18T05:18:35Z","timestamp":1526620715000},"page":"1014-1022","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":61,"title":["Aging and lymphocyte changes by immunomodulatory therapies impact PML risk in multiple sclerosis patients"],"prefix":"10.1177","volume":"24","author":[{"given":"Elizabeth A","family":"Mills","sequence":"first","affiliation":[{"name":"Department of Neurology, University of Michigan Medical School, Ann Arbor, MI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Mao-Draayer","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Michigan Medical School, Ann Arbor, MI, USA\/Graduate Program in Immunology, Program in Biomedical Sciences, University of Michigan Medical School, Ann Arbor, MI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2018,5,18]]},"reference":[{"key":"bibr1-1352458518775550","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1107829"},{"key":"bibr2-1352458518775550","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24286"},{"key":"bibr3-1352458518775550","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1214233"},{"key":"bibr4-1352458518775550","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000003081"},{"key":"bibr5-1352458518775550","doi-asserted-by":"publisher","DOI":"10.1177\/1352458513477925"},{"key":"bibr6-1352458518775550","doi-asserted-by":"publisher","DOI":"10.1111\/ene.12304"},{"key":"bibr7-1352458518775550","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1055\/s-0036-1583609","volume":"47","author":"Hennes EM","year":"2016","journal-title":"Neuropediatrics"},{"key":"bibr8-1352458518775550","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1005719"},{"key":"bibr9-1352458518775550","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.1988.tb03661.x"},{"key":"bibr10-1352458518775550","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2017.01.006"},{"key":"bibr11-1352458518775550","doi-asserted-by":"publisher","DOI":"10.1177\/2055217315596994"},{"key":"bibr12-1352458518775550","doi-asserted-by":"publisher","DOI":"10.1007\/s11357-012-9393-y"},{"key":"bibr13-1352458518775550","doi-asserted-by":"publisher","DOI":"10.2174\/1876326X01206010083"},{"key":"bibr14-1352458518775550","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2963"},{"key":"bibr15-1352458518775550","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1118450109"},{"key":"bibr16-1352458518775550","doi-asserted-by":"publisher","DOI":"10.1016\/0531-5565(94)90073-6"},{"key":"bibr17-1352458518775550","doi-asserted-by":"publisher","DOI":"10.1007\/s10522-008-9138-6"},{"key":"bibr18-1352458518775550","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2567.2011.03470.x"},{"key":"bibr19-1352458518775550","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2018.01.011"},{"key":"bibr20-1352458518775550","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.181.11.7977"},{"key":"bibr21-1352458518775550","doi-asserted-by":"publisher","DOI":"10.1111\/j.1474-9726.2012.00867.x"},{"key":"bibr22-1352458518775550","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20041395"},{"key":"bibr23-1352458518775550","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-009-0718-3"},{"key":"bibr24-1352458518775550","volume-title":"TYSABRI\u00ae (natalizumab): PML in patients receiving Tysabri (USA Tysabri PML update)","author":"Biogen","year":"2017"},{"key":"bibr25-1352458518775550","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20858"},{"key":"bibr26-1352458518775550","doi-asserted-by":"publisher","DOI":"10.1007\/s13365-016-0427-6"},{"key":"bibr27-1352458518775550","doi-asserted-by":"publisher","DOI":"10.1177\/1352458517728814"},{"key":"bibr28-1352458518775550","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2011.05.005"},{"key":"bibr29-1352458518775550","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3182a84101"},{"key":"bibr30-1352458518775550","doi-asserted-by":"publisher","DOI":"10.1007\/s13365-017-0561-9"},{"key":"bibr31-1352458518775550","doi-asserted-by":"publisher","DOI":"10.1186\/1742-4933-7-5"},{"key":"bibr32-1352458518775550","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1302509"},{"key":"bibr33-1352458518775550","doi-asserted-by":"publisher","DOI":"10.1177\/1352458514536085"},{"key":"bibr34-1352458518775550","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.65.12.noc80051"},{"key":"bibr35-1352458518775550","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.165.8.4338"},{"key":"bibr36-1352458518775550","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0034103"},{"key":"bibr37-1352458518775550","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/897249"},{"key":"bibr38-1352458518775550","doi-asserted-by":"publisher","DOI":"10.3109\/13550289809113482"},{"key":"bibr39-1352458518775550","doi-asserted-by":"publisher","DOI":"10.1086\/318120"},{"key":"bibr40-1352458518775550","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00202-11"},{"key":"bibr41-1352458518775550","doi-asserted-by":"publisher","DOI":"10.1038\/nature17979"},{"key":"bibr42-1352458518775550","doi-asserted-by":"publisher","DOI":"10.1177\/1352458511421919"},{"key":"bibr43-1352458518775550","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0034493"},{"key":"bibr44-1352458518775550","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000327341.89587.76"},{"key":"bibr45-1352458518775550","volume-title":"Tecfidera (Biogen Inc.): FDA package insert","author":"Biogen","year":"2017"},{"key":"bibr46-1352458518775550","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1413724"},{"key":"bibr47-1352458518775550","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000002900"},{"key":"bibr48-1352458518775550","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00278"},{"key":"bibr49-1352458518775550","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1601532"},{"key":"bibr50-1352458518775550","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M112.383380"},{"key":"bibr51-1352458518775550","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1747.2003.12605.x"},{"key":"bibr52-1352458518775550","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1997.6570"},{"key":"bibr53-1352458518775550","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.251"},{"key":"bibr54-1352458518775550","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3248"},{"key":"bibr55-1352458518775550","doi-asserted-by":"publisher","DOI":"10.1038\/nature02284"},{"key":"bibr56-1352458518775550","doi-asserted-by":"publisher","DOI":"10.1038\/44385"},{"key":"bibr57-1352458518775550","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000177"},{"key":"bibr58-1352458518775550","unstructured":"Novartis. Gilenya (Novartis Pharmaceuticals Corporation): FDA package insert, 2016."},{"key":"bibr59-1352458518775550","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000327609.57688.ea"},{"key":"bibr60-1352458518775550","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2016.07.015"},{"key":"bibr61-1352458518775550","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-015-0460-z"},{"key":"bibr62-1352458518775550","doi-asserted-by":"publisher","DOI":"10.1159\/000362982"},{"key":"bibr63-1352458518775550","doi-asserted-by":"publisher","DOI":"10.1177\/1352458515574895"},{"key":"bibr64-1352458518775550","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-017-0817-6"},{"key":"bibr65-1352458518775550","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3182143564"},{"key":"bibr66-1352458518775550","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1400118"},{"key":"bibr67-1352458518775550","unstructured":"Novartis. Internal data file, 2017."},{"key":"bibr68-1352458518775550","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-10-186999"},{"key":"bibr69-1352458518775550","doi-asserted-by":"publisher","DOI":"10.1002\/art.38107"},{"key":"bibr70-1352458518775550","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1212\/WNL.86.16_supplement.P2.158","volume":"86","author":"Hardeman P","year":"2016","journal-title":"Neurology"},{"key":"bibr71-1352458518775550","doi-asserted-by":"publisher","DOI":"10.1177\/1756285614546855"},{"key":"bibr72-1352458518775550","first-page":"83","volume":"90","author":"Lorefice L","year":"2017","journal-title":"Is teriflunomide the felon?"},{"key":"bibr73-1352458518775550","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000403"},{"key":"bibr74-1352458518775550","first-page":"282","volume":"86","author":"Wiendl H","year":"2016","journal-title":"Neurology"},{"key":"bibr75-1352458518775550","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2017.0676"},{"key":"bibr76-1352458518775550","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-016-0394-8"},{"key":"bibr77-1352458518775550","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2011-300826"},{"key":"bibr78-1352458518775550","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000000520"},{"key":"bibr79-1352458518775550","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2567.2009.03115.x"},{"key":"bibr80-1352458518775550","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2013.04.018"},{"key":"bibr81-1352458518775550","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3182a35215"},{"key":"bibr82-1352458518775550","doi-asserted-by":"publisher","DOI":"10.1016\/j.mad.2005.11.001"},{"key":"bibr83-1352458518775550","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2012.04644.x"},{"key":"bibr84-1352458518775550","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2014.11.005"},{"key":"bibr85-1352458518775550","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2010.08.004"},{"key":"bibr86-1352458518775550","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0047578"},{"key":"bibr87-1352458518775550","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201142108"},{"key":"bibr88-1352458518775550","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181a8266f"},{"key":"bibr89-1352458518775550","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000210"},{"key":"bibr90-1352458518775550","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0111115"},{"key":"bibr91-1352458518775550","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2016.03.012"},{"key":"bibr92-1352458518775550","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.155"},{"key":"bibr93-1352458518775550","doi-asserted-by":"publisher","DOI":"10.1007\/s11481-013-9465-5"},{"key":"bibr94-1352458518775550","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000211"},{"key":"bibr95-1352458518775550","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2006.06.029"}],"container-title":["Multiple Sclerosis Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1352458518775550","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1352458518775550","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1352458518775550","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T03:54:51Z","timestamp":1777694091000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1352458518775550"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,18]]},"references-count":95,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["10.1177\/1352458518775550"],"URL":"https:\/\/doi.org\/10.1177\/1352458518775550","relation":{},"ISSN":["1352-4585","1477-0970"],"issn-type":[{"value":"1352-4585","type":"print"},{"value":"1477-0970","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,18]]}}}